Krystal Biotech, Inc. (KRYS)
270.26
-2.39
(-0.88%)
USD |
NASDAQ |
Feb 12, 16:00
270.10
-0.16
(-0.06%)
After-Hours: 20:00
Krystal Biotech Cash from Investing (Quarterly) : -4.286M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | -1.299M |
| DexCom, Inc. | 192.80M |
| Alkermes Plc | -6.737M |
| Regeneron Pharmaceuticals, Inc. | 220.30M |
| Alnylam Pharmaceuticals, Inc. | 501.11M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 39.66M |
| Cash from Financing (Quarterly) | 3.709M |
| Free Cash Flow | 165.59M |
| Free Cash Flow Per Share (Quarterly) | 1.272 |
| Free Cash Flow to Equity (Quarterly) | 38.12M |
| Free Cash Flow to Firm (Quarterly) | 37.96M |
| Free Cash Flow Yield | 2.05% |